危重血液系统恶性肿瘤患者动脉氧分压与死亡率的相关性:国际协作网络研究结果
该研究纳入欧洲、加拿大、大洋洲三个国际队列中接受呼吸支持(无创通气、经鼻高流量氧疗、有创机械通气)的危重血液系统恶性肿瘤患者11,249例,用混合效应Cox模型分析第1天PaO2或过量氧疗(吸入氧浓度≥0.6且PaO2>100 mmHg)与28天死亡率的关系。第1天正常氧血症(60≤PaO2≤100 mmHg)5716例(50.8%)、低氧血症(PaO2<60 mmHg)1454例(12.9%)、高氧血症(PaO2>100 mmHg)4079例(36.3%),过量氧疗2201例(20%)。28天粗死亡率为40.6%,PaO2与28天死亡率呈U型关系(p<0.001),PaO2>100 mmHg与28天死亡率存在剂量效应关系。过量氧疗与28天死亡率相关(aHR 1.11,95%CI 1.04-1.19),倾向性评分分析后仍持续(匹配HR 1.31,95%CI 1.20-1.44)。
要点
- 11,249例危重血液系统恶性肿瘤患者中,第1天高氧血症(PaO2>100 mmHg)占36.3%,与28天死亡率呈U型关系(p<0.001),PaO2>100 mmHg存在剂量效应关系。
- 过量氧疗(FiO2≥0.6且PaO2>100 mmHg)占20%,与28天死亡率相关:aHR 1.11(95%CI 1.04-1.19),倾向性评分匹配后HR 1.31(95%CI 1.20-1.44)。
- 亚组分析显示,高氧血症与死亡率的相关性在因神经系统疾病入院者中存在,而在脓毒症和中性粒细胞减少患者中关系相反。
- 28天粗死亡率为40.6%;第1天正常氧血症(60≤PaO2≤100 mmHg)占50.8%,低氧血症(PaO2<60 mmHg)占12.9%。
- 作者认为高氧血症和过量氧疗可能是改善危重血液系统恶性肿瘤患者死亡率的可调控因素。
适用人群与场景
- 来自欧洲、加拿大、大洋洲三个国际队列的危重血液系统恶性肿瘤患者,均接受呼吸支持(无创通气、经鼻高流量氧疗、有创机械通气)。
诊断标准与关键阈值
- 正常氧血症:60≤PaO2≤100 mmHg;低氧血症:PaO2<60 mmHg;高氧血症:PaO2>100 mmHg。
- 过量氧疗定义为吸入氧浓度≥0.6且PaO2>100 mmHg。
研究设计与关键结果
- 研究类型:三个国际队列(欧洲、加拿大、大洋洲)的观察性研究,共纳入11,249例接受呼吸支持的危重血液系统恶性肿瘤患者。
- 第1天氧合状态分布:正常氧血症5716例(50.8%),低氧血症1454例(12.9%),高氧血症4079例(36.3%);过量氧疗2201例(20%)。
- 28天粗死亡率为40.6%。
- PaO2与28天死亡率呈显著U型关系(p<0.001);PaO2>100 mmHg与28天死亡率存在剂量效应关系。
- 亚组分析:高氧血症与死亡率的相关性在因神经系统疾病入院患者中存在,但在脓毒症和中性粒细胞减少患者中关系相反。
- 过量氧疗与28天死亡率相关:aHR 1.11(95%CI 1.04-1.19);倾向性评分分析后匹配HR 1.31(95%CI 1.20-1.44)。
证据类型、等级与局限
- 证据类型:基于三个国际队列的观察性研究,采用混合效应Cox模型和倾向性评分分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在危重血液系统恶性肿瘤患者中,第1天高氧血症(PaO2>100 mmHg)和过量氧疗(FiO2≥0.6且PaO2>100 mmHg)与28天死亡率增加相关,作者认为这可能是改善死亡率的可调控因素。
- 高氧血症与死亡率的关系因亚组而异:因神经系统疾病入院者中存在关联,而脓毒症和中性粒细胞减少患者中关系相反。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Patients with hematological malignancies are at high risk for life-threatening complications. To date, little attention has been paid to the impact of hyperoxemia and excess oxygen use on mortality. The aim of this study was to investigate the association between partial pressure of arterial oxygen (PaO2) and 28-day mortality in critically ill patients with hematologic malignancies.
METHODS: Data from three international cohorts (Europe, Canada, Oceania) of patients who received respiratory support (noninvasive ventilation, high-flow nasal cannula, invasive mechanical ventilation) were obtained. We used mixed-effect Cox models to investigate the association between day one PaO2 or excess oxygen use (inspired fraction of oxygen ≥ 0.6 with PaO2 > 100 mmHg) on day-28 mortality.
RESULTS: 11,249 patients were included. On day one, 5716 patients (50.8%) had normoxemia (60 ≤ PaO2 ≤ 100 mmHg), 1454 (12.9%) hypoxemia (PaO2 < 60 mmHg), and 4079 patients (36.3%) hyperoxemia (PaO2 > 100 mmHg). Excess oxygen was used in 2201 patients (20%). Crude day-28 mortality rate was 40.6%. There was a significant association between PaO2 and day-28 mortality with a U-shaped relationship (p < 0.001). Higher PaO2 levels (> 100 mmHg) were associated with day-28 mortality with a dose-effect relationship. Subgroup analyses showed an association between hyperoxemia and mortality in patients admitted with neurological disorders; however, the opposite relationship was seen across those admitted with sepsis and neutropenia. Excess oxygen use was also associated with subsequent day-28 mortality (adjusted hazard ratio (aHR) [95% confidence interval (CI)]: 1.11[1.04-1.19]). This result persisted after propensity score analysis (matched HR associated with excess oxygen:1.31 [1.20-1.1.44]).
CONCLUSION: In critically-ill patients with hematological malignancies, exposure to hyperoxemia and excess oxygen use were associated with increased mortality, with variable magnitude across subgroups. This might be a modifiable factor to improve mortality.
参考来源
- Dumas G, Morris IS, Hensman T, et al. Association between arterial oxygen and mortality across critically ill patients with hematologic malignancies: results from an international collaborative network. Intensive Care Med. 2024. PMID: 38598124. doi:10.1007/s00134-024-07389-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。